These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 8929948)

  • 1. A genetic register for von Hippel-Lindau disease.
    Maddock IR; Moran A; Maher ER; Teare MD; Norman A; Payne SJ; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans DG
    J Med Genet; 1996 Feb; 33(2):120-7. PubMed ID: 8929948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.
    Furness H; Salfity L; Devereux J; Halliday D; Hanson H; Ruddy DM; Uk Vhl Study Group ; Shah N; Sultana G; Woodward ER; Sandford RN; Snape KM; Maher ER
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.
    Maher ER; Yates JR; Ferguson-Smith MA
    J Med Genet; 1990 May; 27(5):311-4. PubMed ID: 2352258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rational approach to radiological screening in von Hippel-Lindau disease.
    Harries RW
    J Med Screen; 1994 Apr; 1(2):88-95. PubMed ID: 8790493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma.
    Neumann HP; Bender BU; Berger DP; Laubenberger J; Schultze-Seemann W; Wetterauer U; Ferstl FJ; Herbst EW; Schwarzkopf G; Hes FJ; Lips CJ; Lamiell JM; Masek O; Riegler P; Mueller B; Glavac D; Brauch H
    J Urol; 1998 Oct; 160(4):1248-54. PubMed ID: 9751329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
    Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
    Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
    Wittström E; Nordling M; Andréasson S
    Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of screening in von Hippel-Lindau disease--comparison of morbidity associated with initial tumours in affected parents and children.
    Priesemann M; Davies KM; Perry LA; Drake WM; Chew SL; Monson JP; Savage MO; Johnston LB
    Horm Res; 2006; 66(1):1-5. PubMed ID: 16651847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multigenerational kindred.
    Atuk NO; Stolle C; Owen JA; Carpenter JT; Vance ML
    J Clin Endocrinol Metab; 1998 Jan; 83(1):117-20. PubMed ID: 9435426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.
    Hes FJ; McKee S; Taphoorn MJ; Rehal P; van Der Luijt RB; McMahon R; van Der Smagt JJ; Dow D; Zewald RA; Whittaker J; Lips CJ; MacDonald F; Pearson PL; Maher ER
    J Med Genet; 2000 Dec; 37(12):939-43. PubMed ID: 11106358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease.
    Binderup MLM; Stendell AS; Galanakis M; Møller HU; Kiilgaard JF; Bisgaard ML
    Br J Ophthalmol; 2018 Jul; 102(7):942-947. PubMed ID: 28972023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
    Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
    Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy.
    Binderup ML; Budtz-Jørgensen E; Bisgaard ML
    Neurology; 2015 Oct; 85(17):1500-3. PubMed ID: 26408493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Hippel-Lindau disease in a Newfoundland kindred.
    Green JS; Bowmer MI; Johnson GJ
    CMAJ; 1986 Jan; 134(2):133-8, 146. PubMed ID: 3942913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects.
    Webster AR; Richards FM; MacRonald FE; Moore AT; Maher ER
    Am J Hum Genet; 1998 Oct; 63(4):1025-35. PubMed ID: 9758595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortality.
    Bender BU; Eng C; Olschewski M; Berger DP; Laubenberger J; Altehöfer C; Kirste G; Orszagh M; van Velthoven V; Miosczka H; Schmidt D; Neumann HP
    J Med Genet; 2001 Aug; 38(8):508-14. PubMed ID: 11483638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and natural history of von Hippel-Lindau disease.
    Maher ER; Yates JR; Harries R; Benjamin C; Harris R; Moore AT; Ferguson-Smith MA
    Q J Med; 1990 Nov; 77(283):1151-63. PubMed ID: 2274658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.